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The pathology of osteogenesis imperfecta
Osteogenesis imperfecta is a group of related, inherited disorders of connective tissues affecting approximately 1 in 30 000 of the population.' The basic defect is abnormal synthesis of type I collagen molecules.
There are four main classes of osteogenesis imperfecta, designated I-IV with subclasses. Each class is named by reference to the genetic abnormality or clinical features, or both. Thus type I is known as dominant with blue sclerae; type II as lethal perinatal; type III as progressive deforming; and type IV as dominant with normal sclerae.
As the names indicate, some forms of the disease are transmitted as autosomal dominant disorders, and by inference, others have autosomal recessive characteristics. The four classes encompass numerous gene defects caused by deletions, mutations and insertions in the genes controlling formation of type I collagen. 2 Collagen is synthesised from three promolecules known as alpha chains. Within any type of collagen the chains may be all the same or different, but structurally related, molecules. The chains have designations such as alpha 1 (I) (the alpha 1 chain type I collagen). In the cell each alpha chain is altered, by cleavage, hydroxylation and glycosylation, before being combined with the other two to form a triple helix. The resultant molecule is known as procollagen.
The procollagen molecule is exported from the cell and, in the extracellular environment, the triple helix region is cleaved from its propeptides and assembled into collagen microfibrils. These then polymerise, often with other types of collagen, to form fibrils.
The genetic defects in osteogenesis imperfecta affect intracellular events in the process of synthesis and assembly of type I procollagen. Specifically, each subclass is characterised by abnormalities in the genes encoding the synthesis of the pro-alpha 1 (I) or pro-alpha 2 (I) chains, resulting in formation of (a) insufficient normal molecules; (b) unstable molecule; or (c) molecules that will not form helices. A transgenic model exists in mice in which a mutant gene for pro-alpha 1 (I) has been introduced into the mouse genome.3
The most consistently described effect of abnormal type I collagen synthesis is a relative imbalance in the ratio of type I to type III collagen. Because of the way these two collagens are incorporated into the polymerised fibril, the most striking abnormality on ultrastructural examination of the tissue is a decrease in collagen fibre size. 4 Pathologically, the effects of these abnormal collagen fibrils are seen in those tissues which are particularly reliant on collagen fibre integrity for normal function. These include bone matrix, sclerae, dentine, tendons, blood vessels, and skin.' Osteogenesis imperfecta usually presents with the consequence of poor bone formation and decreased bone mass, typically as vertebral and long bone fracture. In addition, the sclerae may appear blue because they are thinned and translucent, permitting partial visualisation of the underlying choroid; there are complex changes in tooth formation leading to small blue-yellow misshapen teeth; tendons and ligaments become lax, permitting an abnormal degree of joint movement; blood vessel walls become weakened; and the texture and resilience of skin becomes abnormal.
As its name suggests type II osteogenesis imperfecta has a very poor outlook. The altered collagen structure makes all the bones "brittle" and, as a consequence, the child is born with multiple fractures leading to trauma to the brain and poor ventilation.
Because it is a rare disease the pathological features of other forms of osteogenesis imperfecta tend to be reported anecdotally. In Given the anniversary being celebrated this year, it is appropriate that this issue of the Journal should contain an article presenting the results of a survey which was designed primarily to discover the culture success rates and quality of the cytogenetic service currently being provided by 30 of the UK's cytogenetic laboratories.2 As many of the clinicians referring tissue biopsy specimens from spontaneous abortions, fetal remains, stillbirths, and neonatal deaths for chromosome studies are pathologists, the results and recommendations of this study provide useful and practical guidelines on how to optimise the chance of successfully achieving a cytogenetic result from these specimens. One striking result was the high rate of maternal cell contamination following the culture of tissues derived from products of conception, the majority comprising early gestation spontaneous abortions. Although many couples who suffer early pregnancy loss may want to know whether a chromosome abnormality accounted for the miscarriage, the high rate of maternal cell contamination means that, in a high proportion of such specimens, the maternal karyotype is inadvertently examined. The most appropriate test, therefore, in couples with a history of recurrent miscarriages remains the examination of the parental chromosomes.
As cytogeneticists reflect on the first 40 years of their profession, it may be an appropriate time to determine how changes in the provision of cytogenetic services have evolved during this time and how they will develop in the next few years. The basic technical principles used by Tjio and Levan provide the foundation of many of the conventional cytogenetic techniques still widely used. hIowever, cytogenetics has seen many scientific and technical advances over the past 40 years. Of these perhaps the most significant is the use of fluorescence in situ hybridisation (FISH) techniques, which is an approach to genetic diagnosis providing an essential bridge between genes and chromosomes. Most cytogenetic laboratories now routinely offer FISH for the diagnosis of a number of subtle chromosome abnormalities below the resolution of conventional microscopy-for example, microdeletion syn- 
